Who adverse event grading scale

who adverse event grading scale

Using the EdCaN resources Case-based learning resources Supporting resources The cancer journey Population health concepts The biology of cancer Cancer treatment planning Surgery Radiotherapy Antineoplastic agents Overview Role of antineoplastics Key concepts Classification Selection and administration Administration principles Models of care Responses Toxicity grading scales References Targeted therapies Stem cell transplantation Supportive care Aboriginal and Torres Strait Islander peoples Entry to specialty program.

CTCAE is intended to be an agreed on terminology for the designation, reporting and grading of AEs that occur in oncology research. With the availability of new agents and the multimodality interventions, it is critical to systematically monitor the AEs that are linked to oncology research.

who adverse event grading scale

Toxicity grading scales provide consistency in reporting, and provide a framework for assessment and documentation of adverse effects. Skip to main content.

Back to Cancer Australia's website.

who adverse event grading scale

Each AE term is defined and accompanied by a grading scale that indicates the severity of the AE. Objective assessment of the impact of treatment may inform the need for adjustments to the treatment plan.